Furthermore, we evaluated the prognostic significance of TRIM50 expression in GSE57495 dataset and our cohort, both of which showed that pancreatic cancer patients with high TRIM50 expression had more favorable prognosis than those with low TRIM50 expression (Figures 1F, G). This evidence concerns the gene TRIM50 and familial pancreatic carcinoma.